Koninklijke Philips Cash on Hand 2010-2024 | PHG

Koninklijke Philips cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Koninklijke Philips cash on hand for the quarter ending September 30, 2024 was $2.018B, a 58.76% increase year-over-year.
  • Koninklijke Philips cash on hand for 2023 was $2.075B, a 50.78% increase from 2022.
  • Koninklijke Philips cash on hand for 2022 was $1.376B, a 50.84% decline from 2021.
  • Koninklijke Philips cash on hand for 2021 was $2.799B, a 26.43% decline from 2020.
Koninklijke Philips Annual Cash on Hand
(Millions of US $)
2023 $2,075
2022 $1,376
2021 $2,799
2020 $3,805
2019 $1,597
2018 $2,551
2017 $2,258
2016 $2,806
2015 $2,089
2014 $2,931
2013 $3,487
2012 $5,107
2011 $4,383
2010 $7,746
2009 $6,117
Koninklijke Philips Quarterly Cash on Hand
(Millions of US $)
2024-06-30 $2,018
2023-06-30 $1,056
2023-03-31
2022-06-30 $1,347
2021-06-30 $1,271
2020-06-30 $2,526
2019-06-30 $1,777
2018-06-30 $1,973
2017-06-30 $2,510
2016-12-31 $2,806
2016-09-30 $2,275
2016-06-30 $2,392
2016-03-31 $1,637
2015-12-31 $2,089
2015-09-30 $1,294
2015-06-30 $1,487
2015-03-31 $2,348
2014-12-31 $2,931
2014-09-30 $2,617
2014-06-30 $2,244
2014-03-31 $2,529
2013-12-31 $3,487
2013-09-30 $2,890
2013-06-30 $3,219
2013-03-31 $4,239
2012-12-31 $5,107
2012-09-30 $4,045
2012-06-30 $4,028
2012-03-31 $5,539
2011-12-31 $4,383
2011-09-30 $3,312
2011-06-30 $4,691
2011-03-31 $6,524
2010-12-31 $7,746
2010-09-30 $5,658
2010-06-30 $5,734
2010-03-31 $6,082
2009-12-31 $6,117
2009-09-30 $5,337
2009-06-30 $4,888
2009-03-31 $5,232
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $23.527B $19.663B
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $194.987B 24.87
Stryker (SYK) United States $136.147B 30.68
Boston Scientific (BSX) United States $130.670B 37.57
EssilorLuxottica (ESLOY) France $110.026B 0.00
Medtronic (MDT) Ireland $102.570B 15.24
Haleon (HLN) United Kingdom $43.909B 28.53
Lonza Group Ag (LZAGY) Switzerland $42.293B 0.00
GE HealthCare Technologies (GEHC) United States $35.376B 18.35
ResMed (RMD) United States $33.995B 27.93
Terumo (TRUMY) Japan $28.800B 40.67
Zimmer Biomet Holdings (ZBH) United States $21.064B 13.41
Insulet (PODD) United States $17.996B 71.67
Baxter (BAX) United States $14.756B 9.60
Smith & Nephew SNATS (SNN) United Kingdom $10.838B 0.00
BellRing Brands (BRBR) United States $10.021B 40.32
Bio-Rad Laboratories (BIO) United States $9.125B 31.01
Demant (WILYY) Denmark $7.926B 0.00
Lantheus Holdings (LNTH) United States $6.392B 14.85
Prestige Consumer Healthcare (PBH) United States $3.886B 19.33
Haemonetics (HAE) United States $3.862B 18.85
ICU Medical (ICUI) United States $3.751B 35.71
Perrigo (PRGO) Ireland $3.510B 10.33
Envista Holdings (NVST) United States $3.103B 23.11
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
QuidelOrtho (QDEL) United States $2.894B 18.63
GN Store Nord (GNNDY) Denmark $2.864B 18.36
Neogen (NEOG) United States $2.605B 30.05
LeMaitre Vascular (LMAT) United States $2.074B 50.41
Green Thumb Industries (GTBIF) United States $1.630B 28.52
AtriCure (ATRC) United States $1.465B 0.00
InMode (INMD) Israel $1.444B 8.68
Maravai LifeSciences Holdings (MRVI) United States $1.371B 0.00
AdaptHealth (AHCO) United States $1.304B 9.32
BioLife Solutions (BLFS) United States $1.211B 0.00
Owens & Minor (OMI) United States $0.973B 7.60
CeriBell (CBLL) United States $0.958B 0.00
Curaleaf Holdings (CURLF) Canada $0.955B 0.00
Phibro Animal Health (PAHC) United States $0.883B 15.58
Evolus (EOLS) United States $0.688B 0.00
Omeros (OMER) United States $0.593B 0.00
VAREX IMAGING (VREX) United States $0.593B 26.15
Capricor Therapeutics (CAPR) United States $0.587B 0.00
Surmodics (SRDX) United States $0.572B 0.00
Verano Holdings (VRNOF) United States $0.445B 0.00
Cresco Labs (CRLBF) United States $0.429B 0.00
Quanterix (QTRX) United States $0.383B 0.00
ZimVie (ZIMV) United States $0.373B 31.44
Valneva SE (VALN) France $0.353B 0.00
Biote (BTMD) United States $0.313B 6.86
Viemed Healthcare (VMD) United States $0.312B 29.70
Canopy Growth (CGC) Canada $0.295B 0.00
Cerus (CERS) United States $0.293B 0.00
OraSure Technologies (OSUR) United States $0.283B 18.95
Sanara MedTech (SMTI) United States $0.276B 0.00
Zynex (ZYXI) United States $0.268B 56.00
High Tide (HITI) Canada $0.237B 98.00
Aurora Cannabis (ACB) Canada $0.225B 0.00
Utah Medical Products (UTMD) United States $0.211B 14.54
MacroGenics (MGNX) United States $0.200B 0.00
Sanuwave Health (SNWV) United States $0.188B 2.64
Organigram Holdings (OGI) Canada $0.184B 0.00
TerrAscend (TSNDF) Canada $0.181B 0.00
Brainsway (BWAY) Israel $0.169B 89.60
FitLife Brands (FTLF) United States $0.151B 19.04
Jin Medical (ZJYL) China $0.132B 0.00
TriSalus Life Sciences (TLSI) United States $0.110B 0.00
Quipt Home Medical (QIPT) United States $0.104B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.100B 0.00
Fonar (FONR) United States $0.096B 10.79
Veru (VERU) United States $0.092B 0.00
Exagen (XGN) United States $0.083B 0.00
Rockwell Medical (RMTI) United States $0.066B 34.17
InterCure (INCR) Israel $0.061B 0.00
Apyx Medical (APYX) United States $0.059B 0.00
Jushi Holdings (JUSHF) United States $0.054B 0.00
Modular Medical (MODD) United States $0.050B 0.00
Cytosorbents (CTSO) United States $0.048B 0.00
Safety Shot (SHOT) United States $0.042B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Allurion Technologies (ALUR) United States $0.018B 0.00
Nephros (NEPH) United States $0.016B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Innovative Eyewear (LUCY) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Trinity Biotech (TRIB) Ireland $0.006B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Agape ATP (ATPC) $0.005B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Sharps Technology (STSS) United States $0.003B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 12.82
SNDL (SNDL) Canada $0.000B 0.00